Given the investment horizon of 30 days, and your above average risk tolerance our recommendation regarding Benefitfocus is 'Strong Hold'. Macroaxis provides Benefitfocus buy hold or sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding BNFT positions. The advice algorithm takes into account all of Benefitfocus available fundamental, technical, and predictive indicators you will find on this site. The advice is provided from BNFT buy-and-hold prospective. Check also Benefitfocus Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for muliple equity instruments please use Instant Ratings tool.
For the selected time horizon Benefitfocus has a risk adjusted performance of 0.039, jensen alpha of 0.1645, total risk alpha of 0.3639, sortino ratio of 0.0656 and treynor ratio of 0.0985Macroaxis buy, hold, or sell recommendation module can be used to complement current analysts and expert consensus on Benefitfocus. Our buy, hold, or sell suggestion engine makes use of analyzes the corporation potential to grow using all fundamental data market data available at the time. To make sure Benefitfocus is not overpriced, please confirm all Benefitfocus fundamentals including its Price to Book, Current Ratio, Retained Earnings, as well as the relationship between Net Income and Price to Earnings To Growth . Given that Benefitfocus has Number of Shares Shorted of 4.35M, we suggest you validate Benefitfocus market performance and probability of bankruptcy to make sure the company can sustain itself in the current economic cycle given your prevailing risk tolerance and investing horizon.
Benefitfocus Trading Alerts and Improvement Suggestions
The company reported previous year revenue of 272.66M. Net Loss for the year was (53.71M) with profit before overhead, payroll, taxes, and interest of 129.44M.
Benefitfocus currently holds about 138.39M in cash with (6.71M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.23.
Roughly 75.0% of the company shares are held by institutions such as insurance companies
Benefitfocus currently demonstrates below average downside deviation of 2.77. It has Information Ratio of 0.07 and Jensen Alpha of 0.16. However, we do advice investors to further question Benefitfocus expected returns to make sure all indicators are consistent with the current outlook about its relatively low value at risk.